NCT00077415 2013-05-153-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Completed31 enrolled